utah

Utah 2034 marks 3,000 days to go with new name and statewide engagement push

25 November 2025 - With 3,000 days until the Olympic and Paralympic Winter Games return to the United States, the…

3 hours ago

Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes

LEHI, Utah, Oct. 23, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes…

1 month ago

Jetcraft grows US footprint with new Sales Director appointment

 RALEIGH, N.C., Oct. 6, 2025 /PRNewswire/ -- Jetcraft, the global leader in business aircraft sales, acquisitions and trades, is today announcing…

2 months ago

Lamborghini Urus SE Journey Through Breathtaking Landscape ofZion National Park

Transforming rugged terrain into a playground for the Super SUV Zion National Park, Utah, September 16, 2025 – Lamborghini Esperienza…

2 months ago

Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

LEHI, Utah, Sept. 4, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company developing first-in-class anti-inflammatory therapies, today announced…

3 months ago

Scientists Discuss the Recent CancerVax Breakthrough

The Company's scientific team describes how they successfully disguised cancer cells and tricked immune cells into attacking them and reveals…

3 months ago

St. George, UT Metropolitan Area Grass Replacement Stats on Par with Las Vegas

ST. GEORGE, Utah--(BUSINESS WIRE)--Since 2023, the St. George Metropolitan Area in Utah has replaced nearly 3 million square feet of…

4 months ago

Cirrus Logic to Present at Upcoming Conference

AUSTIN, Texas--(BUSINESS WIRE)--Cirrus Logic, Inc. (Nasdaq: CRUS) announced that Cirrus Logic Chief Financial Officer Jeff Woolard and Executive Vice President…

4 months ago

A New Chapter of Bold Leadership and Unstoppable Growth

LEHI, Utah, July 24, 2025 /PRNewswire/ -- Amare Global, The Mental Wellness Company™, is pleased to announce a powerful new…

4 months ago

Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)

LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies inspired by genetic resilience, today…

6 months ago